Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Medibank Private ( (AU:MPL) ) has issued an update.
Medibank Private reported a solid first-half 2026 result driven by stronger customer engagement, with net resident policyholders up 1.9% to 38,300 over 12 months and non-resident policy units up 0.4%. The group paid $3.5 billion in claims, delivered $130.7 million in customer value and saw 55% of resident policyholders engage with its health and wellbeing services, while its Live Better rewards program surpassed 1 million members.
Group operating profit rose 6.0% to $381.7 million, supported by a 3.5% lift in health insurance profit and a 28.5% increase in Medibank Health segment profit, though underlying NPAT edged down 0.3% to $297.8 million amid lower investment income and ongoing cyber-related costs. The company increased its fully franked interim dividend by 6.4% to 8.3 cents per share and continued to diversify into primary care with the acquisition of Better Medical, reinforcing its strategy to lead a shift toward prevention and early intervention in an Australian health system under growing strain.
The most recent analyst rating on (AU:MPL) stock is a Hold with a A$5.10 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private is a major Australian health insurer and health services provider, operating the Medibank and ahm brands and increasingly focusing on integrated health, primary care and wellbeing services. The group is expanding its role beyond traditional insurance through Medibank Health and Amplar Health, targeting prevention, community and virtual care to support both public and private health systems.
Average Trading Volume: 6,241,065
Technical Sentiment Signal: Buy
Current Market Cap: A$12.45B
Find detailed analytics on MPL stock on TipRanks’ Stock Analysis page.

